Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Public ClinicalTrials.gov record NCT06608927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma
Study identification
- NCT ID
- NCT06608927
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Arcus Biosciences, Inc.
- Industry
- Enrollment
- 610 participants
Conditions and interventions
Conditions
Interventions
- Gemcitabine Drug
- Nab-paclitaxel Drug
- Placebo Drug
- Quemliclustat Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2024
- Primary completion
- Nov 29, 2030
- Completion
- Nov 29, 2030
- Last update posted
- May 7, 2026
2024 – 2030
United States locations
- U.S. sites
- 49
- U.S. states
- 25
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85054 | — |
| Research Site | Tucson | Arizona | 85724 | — |
| Research Site | La Jolla | California | 92093 | — |
| Research Site | Los Alamitos | California | 90720 | — |
| Research Site | Los Angeles | California | 90033-5315 | — |
| Research Site | Roseville | California | 95661 | — |
| Research Site | San Francisco | California | 94158 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Denver | Colorado | 80218 | — |
| Research Site | New Haven | Connecticut | 06520 | — |
| Research Site | Jacksonville | Florida | 32224-1865 | — |
| Research Site | Miami | Florida | 33176 | — |
| Research Site | Atlanta | Georgia | 30318 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Arlington Heights | Illinois | 60005 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Wichita | Kansas | 67208 | — |
| Research Site | Baton Rouge | Louisiana | 70809 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Grand Rapids | Michigan | 49503 | — |
| Research Site | Minneapolis | Minnesota | 55404 | — |
| Research Site | Rochester | Minnesota | 55905 | — |
| Research Site | Hattiesburg | Mississippi | 39401 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | Omaha | Nebraska | 68105 | — |
| Research Site | New Brunswick | New Jersey | 08903-2681 | — |
| Research Site | Buffalo | New York | 14263 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | New York | New York | 10065 | — |
| Research Site | New York | New York | 10128 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | Cleveland | Ohio | 44106 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Philadelphia | Pennsylvania | 19111-2497 | — |
| Research Site | Pittsburgh | Pennsylvania | 15232 | — |
| Research Site | Nashville | Tennessee | 37232 | — |
| Research Site | Austin | Texas | 78705 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | Dallas | Texas | 75390 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | San Antonio | Texas | 78240 | — |
| Research Site | Webster | Texas | 77598 | — |
| Research Site | Fairfax | Virginia | 22031 | — |
| Research Site | Seattle | Washington | 98101 | — |
| Research Site | Spokane | Washington | 99208 | — |
| Research Site | Vancouver | Washington | 98684 | — |
| Research Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06608927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06608927 live on ClinicalTrials.gov.